Clinical trial
One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in…
NCT00142337 · Institut de Recherche pour le Developpement, Other · Completed
Key facts
| NCT number | NCT00142337 |
|---|---|
| Title | One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine |
| Official title | A Phase 2, One Arm, Open Label, Feasibility Study Assessing One Month Zidovudine/Didanosine Postpartum Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine to Prevent Mother to Child Transmission of HIV |
| Lead sponsor | Institut de Recherche pour le Developpement, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Zidovudine (ZDV), Didanosine (ddI) |
| Enrollment | 244 |
| Start date | Dec 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Feb 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Jan 6, 2012 |
| Countries | Thailand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: